Britannica Sources used in this answer

Why do randomized controlled trials involving placebos raise special consent concerns?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Marble portrait bust of Hippocrates atop a tall rectangular base inscribed with an epigram in Greek, displayed against a black background. — Bioethics A Roman bust of Hippocrates, copied from a Greek original, c. 3rd century bce; in the collection of the Antichità di Ostia, Italy.

In the field of bioethics, randomized controlled trials involving placebos raise significant consent concerns because they involve the intentional withholding of potentially effective treatment from participants.12

The primary ethical tension arises when a proven standard of care already exists. Providing a patient with an inert substance instead of an available, effective therapy can expose them to unnecessary risk, particularly in cases involving serious health conditions or disease transmission. This creates a conflict between the scientific requirement for a control group to validate a new intervention and the fundamental ethical duty to prioritize the health and well-being of the individual participant.31

To address these concerns, the Declaration of Helsinki emphasizes that participants must provide informed consent, which requires a clear explanation of the study’s aims, risks, and the nature of the intervention. Ethical review committees play a critical role in this process by scrutinizing whether the use of a placebo is scientifically compelling and ensuring that patients are not placed at risk of irreversible harm.342